Rheumatoid Arthritis
Olokizumab plus methotrexate safe, efficacious through 106 weeks in rheumatoid arthritis
Olokizumab combined with methotrexate for the treatment of rheumatoid arthritis maintains its safety and efficacy profile through 106 weeks, according to data published in Annals of the Rheumatic Diseases.
Enbrel, Stelara to be discounted nearly 70% through Medicare price negotiations
The list prices of Stelara and Enbrel for Medicare users will be discounted nearly 70% come 2026 as a result of the first round CMS price negotiations with drugmakers, the White House has announced.
Biosimilars cost effective vs. leflunomide in rheumatoid arthritis
In patients with rheumatoid arthritis who have an inadequate response to methotrexate, a treatment sequence beginning with a biosimilar appeared cost-effective compared with leflunomide, according to data published in JAMA Network Open.
MACE, malignancies rarer in Latin American patients with rheumatoid arthritis
Latin American patients with rheumatoid arthritis experience fewer serious adverse events, including major adverse cardiovascular events and malignancy, than patients who are not Latin American, according to a study.
Primary Care Physician Guide to Psoriatic Disease
Clinical Presentation of Psoriatic Arthritis
The CASPAR classification criteria for psoriatic arthritis (PsA) identify any one of these as a necessary indication of inflammatory articular disease before the other components of the criteria may be applied. Concurrent psoriasis is not always present in patients with PsA. There may be a history of prior skin disease or perhaps even no skin disease in patients whose initial presentation is joint disease.
Epidemiology and Classification of Psoriatic Arthritis
Genetics and Pathogenesis of Psoriatic Arthritis
Virtual clinic provides rapid, specialized cancer care for patients facing adverse events
Many people who experience side effects from cancer treatment wait nearly a month to see a specialist with the necessary expertise.
Controlling inflammation ‘exceptionally well’ can heal rheumatoid arthritis bone erosions
Strictly controlling inflammation can heal bone erosions in rheumatoid arthritis, a process accompanied by changes in the Wnt signaling pathway, according to a presenter at the 2024 Association of Women in Rheumatology conference.